Breaking News Instant updates and real-time market news.

DMPI

DelMar Pharmaceuticals

$0.51 /

+0.0082 (+1.63%)

08:11
05/05/20
05/05
08:11
05/05/20
08:11

DelMar enrolled 22 patients in arm of Phase 2 clinical study with VAL-083

DelMar Pharmaceuticals announced it has enrolled 22 patients in the adjuvant arm of the Company's ongoing Phase 2 clinical study investigating adjuvant treatment of MGMT-unmethylated glioblastoma multiforme, or GBM, with VAL-083. The adjuvant arm of the Phase 2 study of VAL-083 being conducted at the MD Anderson Cancer Center, or MDACC, is designed to enroll up to 24 newly-diagnosed patients who have undergone surgery and chemoradiation with TMZ but will now receive VAL-083 in place of standard of care TMZ for adjuvant therapy. Additionally, in the recurrent arm of the study, which is also being conducted at MDACC, 72 patients out of a planned 83 patients have now been enrolled. DelMar continues to actively enroll patients in both trial arms of the clinical study, even in light of the COVID-19 pandemic.

DMPI DelMar Pharmaceuticals
$0.51 /

+0.0082 (+1.63%)

09/06/19 Maxim
DelMar Pharmaceuticals initiated with a Buy at Maxim

TODAY'S FREE FLY STORIES

General news
Oil Action:The weekly Baker-Hughes rig count » 13:35
05/29/20
05/29
13:35
05/29/20
13:35

Oil Action:The weekly…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Occidental Petroleum cuts quarterly dividend to 1c from 11c » 13:30
05/29/20
05/29
13:30
05/29/20
13:30
OXY

Occidental Petroleum

$13.15 /

-0.505 (-3.70%)

Occidental Petroleum said…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OXY Occidental Petroleum
$13.15 /

-0.505 (-3.70%)

OXY Occidental Petroleum
$13.15 /

-0.505 (-3.70%)

05/18/20 Standpoint Research
Occidental Petroleum upgraded to Buy from Hold at Standpoint Research
05/07/20
Fly Intel: Top five analyst upgrades
05/07/20 SunTrust
Occidental Petroleum upgraded to Hold from Sell at SunTrust
05/06/20 SunTrust
Occidental Petroleum upgraded to Hold from Sell at SunTrust
OXY Occidental Petroleum
$13.15 /

-0.505 (-3.70%)

OXY Occidental Petroleum
$13.15 /

-0.505 (-3.70%)

OXY Occidental Petroleum
$13.15 /

-0.505 (-3.70%)

OXY Occidental Petroleum
$13.15 /

-0.505 (-3.70%)

Recommendations
NextCure data shows S15-mediated activity, says Piper Sandler » 13:25
05/29/20
05/29
13:25
05/29/20
13:25
NXTC

NextCure

$31.62 /

-1.54 (-4.64%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NXTC NextCure
$31.62 /

-1.54 (-4.64%)

NXTC NextCure
$31.62 /

-1.54 (-4.64%)

05/26/20 JMP Securities
NextCure initiated with an Outperform at JMP Securities
04/13/20 Piper Sandler
NextCure could report Phase I biomarker data at ASCO, says Piper Sandler
03/24/20 Benchmark
NextCure initiated with a Buy at Benchmark
03/02/20 Roth Capital
NextCure initiated with a Buy at Roth Capital
NXTC NextCure
$31.62 /

-1.54 (-4.64%)

Recommendations
Polymetal price target lowered to 1,800 GBp from 1,925 GBp at RBC Capital » 13:23
05/29/20
05/29
13:23
05/29/20
13:23
AUCOY

Polymetal

$0.00 /

+ (+0.00%)

RBC Capital analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AUCOY Polymetal
$0.00 /

+ (+0.00%)

05/07/20 Morgan Stanley
Polymetal price target raised to 1,550 GBp from 1,150 GBp at Morgan Stanley
05/04/20 Berenberg
Polymetal price target raised to 1,680 GBp from 1,570 GBp at Berenberg
04/30/20 JPMorgan
Polymetal price target raised to 1,800 GBp from 1,500 GBp at JPMorgan
04/29/20 RBC Capital
Polymetal price target raised to 1,825 GBp from 1,650 GBp at RBC Capital
Hot Stocks
Occidental Petroleum trading halted, news pending  13:23
05/29/20
05/29
13:23
05/29/20
13:23
OXY

Occidental Petroleum

$13.13 /

-0.52 (-3.81%)

 
ShowHide Related Items >><<
OXY Occidental Petroleum
$13.13 /

-0.52 (-3.81%)

OXY Occidental Petroleum
$13.13 /

-0.52 (-3.81%)

05/18/20 Standpoint Research
Occidental Petroleum upgraded to Buy from Hold at Standpoint Research
05/07/20
Fly Intel: Top five analyst upgrades
05/07/20 SunTrust
Occidental Petroleum upgraded to Hold from Sell at SunTrust
05/06/20 SunTrust
Occidental Petroleum upgraded to Hold from Sell at SunTrust
OXY Occidental Petroleum
$13.13 /

-0.52 (-3.81%)

OXY Occidental Petroleum
$13.13 /

-0.52 (-3.81%)

OXY Occidental Petroleum
$13.13 /

-0.52 (-3.81%)

OXY Occidental Petroleum
$13.13 /

-0.52 (-3.81%)

Downgrade
Jefferies downgrades Minerva to Hold on unclear path for roluperidone » 13:21
05/29/20
05/29
13:21
05/29/20
13:21
NERV

Minerva

$3.78 /

-9.7 (-71.96%)

Jefferies analyst Biren…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NERV Minerva
$3.78 /

-9.7 (-71.96%)

NERV Minerva
$3.78 /

-9.7 (-71.96%)

13:17 Today Jefferies
Minerva downgraded to Hold from Buy at Jefferies
12:34 Today H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
12:28 Today William Blair
Minerva downgraded to Market Perform from Outperform at William Blair
05/14/20 BTIG
Minerva initiated with a Buy at BTIG
NERV Minerva
$3.78 /

-9.7 (-71.96%)

Recommendations
DNO ASA price target lowered to NOK 6.30 from NOK 6.75 at RBC Capital » 13:18
05/29/20
05/29
13:18
05/29/20
13:18
DTNOF

DNO ASA

$0.00 /

+ (+0.00%)

RBC Capital analyst Al…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
Minerva downgraded to Hold from Buy at Jefferies » 13:17
05/29/20
05/29
13:17
05/29/20
13:17
NERV

Minerva

$3.59 /

-9.89 (-73.37%)

Jefferies downgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NERV Minerva
$3.59 /

-9.89 (-73.37%)

NERV Minerva
$3.59 /

-9.89 (-73.37%)

12:34 Today H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
12:28 Today William Blair
Minerva downgraded to Market Perform from Outperform at William Blair
05/14/20 BTIG
Minerva initiated with a Buy at BTIG
05/04/20 JMP Securities
JMP optimistic going into Minerva's Phase 3 schizophrenia readout
NERV Minerva
$3.59 /

-9.89 (-73.37%)

Technical Analysis
NASDAQ market internals summary » 13:17
05/29/20
05/29
13:17
05/29/20
13:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Recommendations
Piper says Iovance data for lifileucel continue to 'mature favorably' » 13:17
05/29/20
05/29
13:17
05/29/20
13:17
IOVA

Iovance Biotherapeutics

$31.56 /

-1.105 (-3.38%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IOVA Iovance Biotherapeutics
$31.56 /

-1.105 (-3.38%)

IOVA Iovance Biotherapeutics
$31.56 /

-1.105 (-3.38%)

05/28/20 Piper Sandler
Iovance melanoma data 'fully supportive of approval,' says Piper Sandler
04/29/20 Oppenheimer
Iovance Biotherapeutics price target raised to $43 from $35 at Oppenheimer
04/29/20 H.C. Wainwright
Iovance Biotherapeutics price target raised to $48 from $36 at H.C. Wainwright
04/27/20 Piper Sandler
AACR abstract for Moffitt study positive for Iovance, says Piper Sandler
IOVA Iovance Biotherapeutics
$31.56 /

-1.105 (-3.38%)

  • 29
    May
IOVA Iovance Biotherapeutics
$31.56 /

-1.105 (-3.38%)

IOVA Iovance Biotherapeutics
$31.56 /

-1.105 (-3.38%)

IOVA Iovance Biotherapeutics
$31.56 /

-1.105 (-3.38%)

Technical Analysis
NYSE market internals summary » 13:16
05/29/20
05/29
13:16
05/29/20
13:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Recommendations
AB InBev price target raised to EUR 53 from EUR 50 at RBC Capital » 13:12
05/29/20
05/29
13:12
05/29/20
13:12
BUD

AB InBev

$46.32 /

-1.08 (-2.28%)

RBC Capital analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BUD AB InBev
$46.32 /

-1.08 (-2.28%)

BUD AB InBev
$46.32 /

-1.08 (-2.28%)

05/20/20 JPMorgan
AB InBev upgraded to Neutral from Underweight at JPMorgan
05/13/20 Morgan Stanley
AB InBev price target lowered to EUR 39 from EUR 40 at Morgan Stanley
04/20/20 Morgan Stanley
AB InBev downgraded to Equal Weight from Overweight at Morgan Stanley
04/13/20 Evercore ISI
Beer production not resuming in Mexico, says Evercore ISI
BUD AB InBev
$46.32 /

-1.08 (-2.28%)

BUD AB InBev
$46.32 /

-1.08 (-2.28%)

BUD AB InBev
$46.32 /

-1.08 (-2.28%)

BUD AB InBev
$46.32 /

-1.08 (-2.28%)

Hot Stocks
Tyson says 326 of 1,604 team members tested positive for COVID at Texas plant » 13:10
05/29/20
05/29
13:10
05/29/20
13:10
TSN

Tyson Foods

$60.49 /

-1.32 (-2.14%)

Tyson Foods announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSN Tyson Foods
$60.49 /

-1.32 (-2.14%)

TSN Tyson Foods
$60.49 /

-1.32 (-2.14%)

05/28/20
Fly Intel: Top five analyst downgrades
05/28/20 Argus
Tyson Foods downgraded to Hold from Buy at Argus
05/28/20 Argus
Tyson Foods downgraded to Hold from Buy at Argus
05/05/20
Fly Intel: Top five analyst downgrades
TSN Tyson Foods
$60.49 /

-1.32 (-2.14%)

TSN Tyson Foods
$60.49 /

-1.32 (-2.14%)

TSN Tyson Foods
$60.49 /

-1.32 (-2.14%)

TSN Tyson Foods
$60.49 /

-1.32 (-2.14%)

Recommendations
Adaptimmune data 'incrementally supportive,' but still early, says Mizuho » 13:09
05/29/20
05/29
13:09
05/29/20
13:09
ADAP

Adaptimmune

$11.51 /

+6.65 (+136.83%)

Mizuho analyst Mara…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADAP Adaptimmune
$11.51 /

+6.65 (+136.83%)

ADAP Adaptimmune
$11.51 /

+6.65 (+136.83%)

04/21/20 Mizuho
Adaptimmune initiated with a Neutral at Mizuho
10/23/19
Adaptimmune management to meet with SunTrust
08/02/19
Fly Intel: Top five analyst downgrades
08/02/19 Guggenheim
Adaptimmune downgraded to Neutral on low near-term visibility at Guggenheim
ADAP Adaptimmune
$11.51 /

+6.65 (+136.83%)

ADAP Adaptimmune
$11.51 /

+6.65 (+136.83%)

ADAP Adaptimmune
$11.51 /

+6.65 (+136.83%)

General News
NY Governor Cuomo reports 67 virus deaths vs. 74 deaths the day before » 13:08
05/29/20
05/29
13:08
05/29/20
13:08
SPY

SPDR S&P 500 ETF Trust

$300.46 /

-2.53 (-0.84%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

In his daily COVID-19…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$300.46 /

-2.53 (-0.84%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$300.46 /

-2.53 (-0.84%)

03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
12/16/19 Piper Jaffray
Piper establishes 2020 S&P 500 price objective of 3,600
SPX S&P 500
$0.00 /

+ (+0.00%)

03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
12/16/19 Piper Jaffray
Piper establishes 2020 S&P 500 price objective of 3,600
SPY SPDR S&P 500 ETF Trust
$300.46 /

-2.53 (-0.84%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$300.46 /

-2.53 (-0.84%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$300.46 /

-2.53 (-0.84%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$300.46 /

-2.53 (-0.84%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$300.46 /

-2.53 (-0.84%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Hot Stocks
Wells Fargo names Kevin Reen CRO for consumer lending » 13:07
05/29/20
05/29
13:07
05/29/20
13:07
WFC

Wells Fargo

$26.27 /

-0.95 (-3.49%)

Wells Fargo announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WFC Wells Fargo
$26.27 /

-0.95 (-3.49%)

WFC Wells Fargo
$26.27 /

-0.95 (-3.49%)

10:09 Today
Fly Intel: Top five analyst initiations
07:37 Today
Wells Fargo initiated with a Neutral at DA Davidson
05/28/20 DA Davidson
Wells Fargo initiated with a Neutral at DA Davidson
05/15/20 Cowen
Cowen 'would be surprised' if Goldman tried to buy any big commercial banks
WFC Wells Fargo
$26.27 /

-0.95 (-3.49%)

WFC Wells Fargo
$26.27 /

-0.95 (-3.49%)

WFC Wells Fargo
$26.27 /

-0.95 (-3.49%)

WFC Wells Fargo
$26.27 /

-0.95 (-3.49%)

General news
Baker-Hughes Rig Count N. Amer. data reported » 13:06
05/29/20
05/29
13:06
05/29/20
13:06

Week of 5/29 Baker-Hughes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
FX Action: USD-JPY » 13:05
05/29/20
05/29
13:05
05/29/20
13:05

FX Action: USD-JPY…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Baker Hughes reports U.S. rig count down 17 to 301 rigs » 13:04
05/29/20
05/29
13:04
05/29/20
13:04
BKR

Baker Hughes

$16.17 /

-0.23 (-1.40%)

Baker Hughes reports that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BKR Baker Hughes
$16.17 /

-0.23 (-1.40%)

BKR Baker Hughes
$16.17 /

-0.23 (-1.40%)

08:41 Today Northland
Baker Hughes initiated with a Market Perform at Northland
04/23/20 Citi
Baker Hughes price target raised to $16 from $14 at Citi
04/05/20 Bernstein
Baker Hughes upgraded to Outperform from Underperform at Bernstein
03/31/20
Fly Intel: Top five analyst downgrades
BKR Baker Hughes
$16.17 /

-0.23 (-1.40%)

BKR Baker Hughes
$16.17 /

-0.23 (-1.40%)

BKR Baker Hughes
$16.17 /

-0.23 (-1.40%)

Hot Stocks
Sen. Ted Cruz calls forTwitter to be investigated over Iran sanctions compliance » 13:03
05/29/20
05/29
13:03
05/29/20
13:03
TWTR

Twitter

$30.52 /

-1.08 (-3.42%)

Senator Ted Cruz has sent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$30.52 /

-1.08 (-3.42%)

TWTR Twitter
$30.52 /

-1.08 (-3.42%)

09:28 Today Baird
Twitter, Facebook pullbacks would likely be buying opportunities, says Baird
09:10 Today JPMorgan
Trump order may put 'overhang' on big tech in coming months, says JPMorgan
05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/06/20 China Renaissance
Twitter price target lowered to $23 from $25 at China Renaissance
TWTR Twitter
$30.52 /

-1.08 (-3.42%)

TWTR Twitter
$30.52 /

-1.08 (-3.42%)

TWTR Twitter
$30.52 /

-1.08 (-3.42%)

TWTR Twitter
$30.52 /

-1.08 (-3.42%)

Hot Stocks
Baker Hughes reports U.S. rig count down 17 to 301 rigs  13:01
05/29/20
05/29
13:01
05/29/20
13:01
BKR

Baker Hughes

$16.15 /

-0.255 (-1.55%)

 
ShowHide Related Items >><<
BKR Baker Hughes
$16.15 /

-0.255 (-1.55%)

BKR Baker Hughes
$16.15 /

-0.255 (-1.55%)

08:41 Today Northland
Baker Hughes initiated with a Market Perform at Northland
04/23/20 Citi
Baker Hughes price target raised to $16 from $14 at Citi
04/05/20 Bernstein
Baker Hughes upgraded to Outperform from Underperform at Bernstein
03/31/20
Fly Intel: Top five analyst downgrades
BKR Baker Hughes
$16.15 /

-0.255 (-1.55%)

BKR Baker Hughes
$16.15 /

-0.255 (-1.55%)

BKR Baker Hughes
$16.15 /

-0.255 (-1.55%)

General news
Export Prices data reported. » 12:55
05/29/20
05/29
12:55
05/29/20
12:55

May Export Prices at % …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Import Prices data reported. » 12:55
05/29/20
05/29
12:55
05/29/20
12:55

May Import Prices at % …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
EMA recommends approval of Johnson & Johnson Ebola vaccine » 12:55
05/29/20
05/29
12:55
05/29/20
12:55
JNJ

Johnson & Johnson

$146.31 /

-0.7 (-0.48%)

The European Medicines…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$146.31 /

-0.7 (-0.48%)

JNJ Johnson & Johnson
$146.31 /

-0.7 (-0.48%)

12:34 Today H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
JNJ Johnson & Johnson
$146.31 /

-0.7 (-0.48%)

JNJ Johnson & Johnson
$146.31 /

-0.7 (-0.48%)

JNJ Johnson & Johnson
$146.31 /

-0.7 (-0.48%)

JNJ Johnson & Johnson
$146.31 /

-0.7 (-0.48%)

Periodicals
Sanofi halts recruitment of patients in hydroxychloroquine trials, Reuters says » 12:54
05/29/20
05/29
12:54
05/29/20
12:54
SNY

Sanofi

$48.41 /

-0.26 (-0.53%)

Sanofi is suspending…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$48.41 /

-0.26 (-0.53%)

SNY Sanofi
$48.41 /

-0.26 (-0.53%)

05/28/20 Piper Sandler
Alexion settlement could 'clear the deck' for acquirer, says Piper Sandler
05/27/20 Citi
BioMarin a good takeout candidate, but not by Sanofi, says Citi
05/26/20 UBS
Sanofi price target lowered to EUR 101 from EUR 103 at UBS
05/26/20 Piper Sandler
Piper remains buyer of Regeneron, ups target to $630 on buyback accretion
SNY Sanofi
$48.41 /

-0.26 (-0.53%)

SNY Sanofi
$48.41 /

-0.26 (-0.53%)

SNY Sanofi
$48.41 /

-0.26 (-0.53%)

SNY Sanofi
$48.41 /

-0.26 (-0.53%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.